首页> 外文OA文献 >Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

【2h】

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

机译：双特异性嵌合抗原受体T细胞和间接疫苗在免疫活性剂，自抗原设置中消除各种大型实体瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Clare Y. Slaney; Bianca von Scheidt; Alexander J. Davenport; Paul A. Beavis; Jennifer A. Westwood; Sherly Mardiana; David C. Tscharke; Sarah Ellis; H. Miles Prince; Joseph A. Trapani; Ricky W. Johnstone; Mark J. Smyth; Michele W. Teng; Aesha Ali; Zhiya Yu; Steven A. Rosenberg; Nicholas P. Restifo; Paul Neeson; Phillip K. Darcy; Michael H. Kershaw;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting [J] . Slaney Clare Y., von Scheidt Bianca, Davenport Alexander J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第10期

机译：双特异性嵌合抗原受体T细胞和间接疫苗在免疫活性剂，自抗原设置中消除各种大型实体瘤
2. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models [J] . Progress in Artificial Intelligence . 2020,第1期

机译：B7-H3具有嵌合抗原受体和诱饵PD-1受体的特异性T细胞在小鼠模型中根除已建立的固体人肿瘤
3. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models [J] . Luo, Wang, J., Oncoimmunology. . 2020,第1期

机译：B7-H3具有嵌合抗原受体和诱饵PD-1受体的特异性T细胞在小鼠模型中根除已建立的固体人肿瘤
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Generation of chimeric antigen receptor modified human T lymphocytes for the potent and dual-antigen selective eradication of human cancers in mice. [D] . Kloss, Christopher Carl. 2013

机译：嵌合抗原受体修饰的人T淋巴细胞的产生，可有效和消灭小鼠中的人类癌症。
6. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent Self-antigen Setting [O] . Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, -1

机译：双特异性嵌合抗原受体T细胞和间接疫苗根除免疫能力强自身抗原设置的各种大型实体瘤。
7. Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication [O] . Zhong, Xiao-Song, Matsushita, Maiko, Plotkin, Jason, 2010

机译：结合4-1BB和CD28信号域的嵌合抗原受体增强PI3激酶/ AKT / Bcl-XL激活和CD8 + T细胞介导的肿瘤根除

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting

著录项

相似文献

相关主题

期刊订阅